Authors:
Rosenthal, DI
Lee, JH
Sinard, R
Yardley, DA
Machtay, M
Rosen, DM
Egorin, MJ
Weber, RS
Weinstein, GS
Chalian, AA
Miller, LK
Frenkel, EP
Carbone, DP
Citation: Di. Rosenthal et al., Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma ofthe head and neck, J CL ONCOL, 19(5), 2001, pp. 1363-1373
Citation: Mj. Egorin et al., Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1, CANC CHEMOT, 47(4), 2001, pp. 291-302
Authors:
Fracasso, PM
Westerveldt, P
Fears, CA
Rosen, DM
Zuhowski, EG
Cazenave, LA
Litchman, M
Egorin, MJ
Citation: Pm. Fracasso et al., Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (valspodar), in refractory malignancies, J CL ONCOL, 18(5), 2000, pp. 1124-1134
Authors:
Clemmons, DR
Moses, AC
McKay, MJ
Sommer, A
Rosen, DM
Ruckle, J
Citation: Dr. Clemmons et al., The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: Evidence for in vivo biological activity, J CLIN END, 85(4), 2000, pp. 1518-1524
Authors:
Conley, BA
Ramsland, TS
Sentz, DL
Wu, SL
Rosen, DM
Wollman, M
Eiseman, JL
Citation: Ba. Conley et al., Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice, CANC CHEMOT, 43(3), 1998, pp. 183-197